Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1
- PMID: 19079688
- PMCID: PMC2596337
Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1
Abstract
Sepsis refers to a systemic inflammatory response syndrome resulting from a microbial infection, which kills > 225,000 people annually in the U.S. alone. The high mortality of sepsis is partly mediated by bacterial endotoxin, which stimulates macrophages/monocytes to sequentially release early (e.g., TNF) and late (e.g., HMGB1) pro-inflammatory cytokines. Although early proinflammatory cytokines may be protective against infection, excessive accumulation of late-acting proinflammatory mediators (such as HMGB1) may sustain a potentially injurious inflammatory response. Agents capable of inhibiting HMGB1 activities (e.g., neutralizing antibodies) or release [e.g., Chinese herbs, Danggui (Angelica sinensis), Danshen (Salvia miltiorrhiza) and Green tea (Camellia sinensis)] rescue mice from lethal sepsis even when given 24 hours after onset of the disease. Here we review emerging evidence that support a critical role for extracellular HMGB1 as a late mediator of lethal sepsis, and several commonly used Chinese herbs (Danggui, Danshen and Green tea) as potential HMGB1- targeting therapeutic agents in experimental sepsis.
Keywords: Chinese herbs; Inate immune cells; catechin; cytokines; sepsis; tanshinone.
Figures




Similar articles
-
Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.Shock. 2009 Oct;32(4):348-57. doi: 10.1097/SHK.0b013e3181a551bd. Shock. 2009. PMID: 19333143 Free PMC article. Review.
-
A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1.PLoS One. 2007 Nov 7;2(11):e1153. doi: 10.1371/journal.pone.0001153. PLoS One. 2007. PMID: 17987129 Free PMC article.
-
A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1.J Immunol. 2007 Mar 15;178(6):3856-64. doi: 10.4049/jimmunol.178.6.3856. J Immunol. 2007. PMID: 17339485 Free PMC article.
-
The aqueous extract of a popular herbal nutrient supplement, Angelica sinensis, protects mice against lethal endotoxemia and sepsis.J Nutr. 2006 Feb;136(2):360-5. doi: 10.1093/jn/136.2.360. J Nutr. 2006. PMID: 16424112 Free PMC article.
-
HMGB1 as a potential therapeutic target.Novartis Found Symp. 2007;280:73-85; discussion 85-91, 160-4. Novartis Found Symp. 2007. PMID: 17380789 Review.
Cited by
-
Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.Shock. 2009 Oct;32(4):348-57. doi: 10.1097/SHK.0b013e3181a551bd. Shock. 2009. PMID: 19333143 Free PMC article. Review.
-
Immunomodulatory Effects of Danshen (Salvia miltiorrhiza) in BALB/c Mice.ISRN Inflamm. 2012 Oct 16;2012:954032. doi: 10.5402/2012/954032. eCollection 2012. ISRN Inflamm. 2012. PMID: 24049654 Free PMC article.
-
A Comprehensive View of Frozen Shoulder: A Mystery Syndrome.Front Med (Lausanne). 2021 May 11;8:663703. doi: 10.3389/fmed.2021.663703. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34046418 Free PMC article. Review.
-
Sirt1 restrains lung inflammasome activation in a murine model of sepsis.Am J Physiol Lung Cell Mol Physiol. 2015 Apr 15;308(8):L847-53. doi: 10.1152/ajplung.00274.2014. Epub 2015 Feb 6. Am J Physiol Lung Cell Mol Physiol. 2015. PMID: 25659903 Free PMC article.
-
Therapeutic potential of HMGB1-targeting agents in sepsis.Expert Rev Mol Med. 2008 Nov 4;10:e32. doi: 10.1017/S1462399408000884. Expert Rev Mol Med. 2008. PMID: 18980707 Free PMC article. Review.
References
-
- Ayala A, Song GY, Chung CS, Redmond KM, Chaudry IH. Immune depression in polymicrobial sepsis: the role of necrotic (injured) tissue and endotoxin. Crit Care Med. 2000;28:2949–2955. - PubMed
-
- Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987;330:662–664. - PubMed
-
- Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today. 1991;12:404–410. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources